TRV GP III, LLC's Net Worth
$769 Million
Who is TRV GP III, LLC?
TRV GP III, LLC has an estimated net worth of $769 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Nurix Therapeutics, Inc., Global Blood Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., and Decibel Therapeutics, Inc..
SEC CIK
TRV GP III, LLC's CIK is 0001637299
Past Insider Trading and Trends
2020 was TRV GP III, LLC's most active year for acquiring shares with 11 total transactions. TRV GP III, LLC's most active month to acquire stocks was the month of June. 2021 was TRV GP III, LLC's most active year for disposing of shares, totalling 18 transactions. TRV GP III, LLC's most active month to dispose stocks was the month of December. 2019 saw TRV GP III, LLC paying a total of $1,300,000.00 for 5,676,488 shares, this is the most they've acquired in one year. In 2021 TRV GP III, LLC cashed out on 13,022,394 shares for a total of $243,054,711.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revolution Medicines, Inc. (RVMD) Snapshot price: $29.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.60% | -419.90K |
$20.25 | -$8,502,995.25 | 5.1M |
Jun 8
| |||
Form 4
| -21.36% | -1.50M |
—
|
—
| 5.52M |
Feb 24
| |||
Form 4
| -12.46% | -1.00M |
—
|
—
| 7.02M |
Dec 2
| |||
Form 4
| -11.08% | -1.00M |
—
|
—
| 8.02M |
Sep 9
| |||
Form 4
| +2,560.14% | 10.52M |
—
|
—
| 10.93M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -52.09% | -2.00M |
—
|
—
| 1.84M |
Nov 29
| |||
Form 4
| -34.25% | -2.00M |
—
|
—
| 3.84M |
Scheduled
|
Sep 20
| ||
Form 4
| +2,750.00% | 7.69M |
—
|
—
| 7.97M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Editas Medicine, Inc. (EDIT) Snapshot price: $7.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -16.11% | -750.00K |
—
|
—
| 3.91M |
Aug 16
| |||
Form 4
|
∞
| 4.66M |
—
|
—
| 4.66M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Jounce Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -62.32% | -1.90M |
$8.38 | -$15,922,000.00 | 1.15M |
Nov 12
| |||
Form 4
| +2,350.00% | 12.74M |
—
|
—
| 13.28M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nurix Therapeutics, Inc. (NRIX) Snapshot price: $8.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.08% | -1.09M |
—
|
—
| 3.42M |
Scheduled
|
May 6
| ||
Form 4
| -16.86% | -914.22K |
—
|
—
| 4.51M |
Feb 4
| |||
Form 4
|
∞
| 5.42M |
—
|
—
| 5.42M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |